New York State Department of Health
New York State DOH Approves Solvd Lab for Clinical PGx Testing
The company markets an assay intended to predict patients' risk of developing opioid use disorder, helping physicians tailor their use of these drugs.
New York State DOH Approves Biotia's AI-, Sequencing-Based Urinary Tract Infection Test
The laboratory-developed test uses shotgun metagenomic sequencing to identify pathogens that cause urinary tract infections.
NeoGenomics Wins New York State Approval for Solid Tumor, Lung Cancer NGS Tests
Although the approval is conditional, the company can now offer the tests for physicians and patients in the state.
Geneoscopy Gets Lab Permit From New York State Department of Health
With the New York lab permit, the St. Louis-based company can now offer its ColoSense colon cancer screening test throughout the US.
Applied DNA Sciences to Launch PGx Testing Service in New York State
The company's clinical laboratory subsidiary's pharmacogenomic testing service, TR8 PGx, has been approved by the New York State Department of Health.